Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients

Authors: Cauduro, Rafael L; Costa, Cesar; Lhulier, Francisco; Garcia, Règis G; Cabral, Renan D; Gonçalves, Luiz FS; Manfro, Roberto C

Source: Clinical Transplantation, Volume 19, Number 4, August 2005 , pp. 470-474(5)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Cauduro RL, Costa C, Lhulier F, Garcia RG, Cabral RD, Gonçalves LFS, Manfro RC. Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients.

Clin Transplant 2005: 19: 470–474. © Blackwell Munksgaard, 2005 Abstract: 

Experimental models suggest that endothelin-1 (ET-1) has a significant role in the pathogenesis of cyclosporin A (CyA)-induced hypertension. However, its serum levels evaluated in different studies, including patients who received solid organ transplants, exhibited controversial results. Our study population consisted of 43 renal transplant patients: 33 were taking CyA as a component of their immunosuppressive regimen (CyA group) and 10 that were not taking CyA (control group). Baseline laboratory data, blood pressure and ET-1 levels were taken at baseline and 3 and 4 h after the ingestion of CyA. In the control group samples were collected in the corresponding periods of time. Blood pressure was significantly higher in the CyA group (mean blood pressure: 101.2 ± 9.5 vs. 91.1 ± 10.7 mmHg; p < 0.001), who also presented higher serum creatinine (1.2 ± 0.28 vs. 0.97 ± 0.13 mg/dL; p < 0.001) and ET-1 levels. In the CyA group an ET-1 peak was evident by the third hour after CyA ingestion that showed its maximum concentration after 1–2 h; the control group exhibited significantly lower levels of ET-1 (p = 0.044). ET-1 levels compared between patients with and without hypertension showed a non-statistically significant difference (1.54 ± 0.76 vs. 1.27 ± 0.62 ng/mL; p = 0.27, respectively). In conclusion, in the present study chronic CyA ingestion was associated with higher blood pressure and plasma ET-1 levels.

Keywords: cyclosporine; endothelin-1; hypertension; renal transplantation

Document Type: Research article

DOI: 10.1111/j.1399-0012.2005.00357.x

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A